Sökning: onr:"swepub:oai:DiVA.org:liu-161394" >
Developing neurosci...
-
Heilig, MarkusLinköpings universitet,Centrum för social och affektiv neurovetenskap,Medicinska fakulteten,Region Östergötland, Psykiatriska kliniken inkl beroendekliniken
(författare)
Developing neuroscience-based treatments for alcohol addiction: A matter of choice?
- Artikel/kapitelEngelska2019
Förlag, utgivningsår, omfång ...
-
2019-10-08
-
NATURE PUBLISHING GROUP,2019
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:liu-161394
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-161394URI
-
https://doi.org/10.1038/s41398-019-0591-6DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:for swepub-publicationtype
Anmärkningar
-
Funding Agencies|European UnionEuropean Union (EU) [668863-SyBil-AA]; Swedish Research CouncilSwedish Research Council [2013-07434]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [TRR 265-B08, SFB1134-B04]
-
Excessive alcohol use is the cause of an ongoing public health crisis, and accounts for -5% of global disease burden. A minority of people with recreational alcohol use develop alcohol addiction (hereafter equated with "alcohol dependence" or simply "alcoholism"), a condition characterized by a systematically biased choice preference for alcohol at the expense of healthy rewards, and continued use despite adverse consequences ("compulsivity"). Alcoholism is arguably the most pressing area of unmet medical needs in psychiatry, with only a small fraction of patients receiving effective, evidence-based treatments. Medications currently approved for the treatment of alcoholism have small effect sizes, and their clinical uptake is negligible. No mechanistically new medications have been approved since 2004, and promising preclinical results have failed to translate into novel treatments. This has contributed to a reemerging debate whether and to what extent alcohol addiction represents a medical condition, or reflects maladaptive choices without an underlying brain pathology. Here, we review this landscape, and discuss the challenges, lessons learned, and opportunities to retool drug development in this important therapeutic area.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Augier, EricLinköpings universitet,Centrum för social och affektiv neurovetenskap,Medicinska fakulteten(Swepub:liu)eriau90
(författare)
-
Pfarr, SimoneCent Inst Mental Hlth, Germany
(författare)
-
Sommer, Wolfgang H.Cent Inst Mental Hlth, Germany; Cent Inst Mental Hlth, Germany
(författare)
-
Linköpings universitetCentrum för social och affektiv neurovetenskap
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Translational Psychiatry: NATURE PUBLISHING GROUP92158-3188
Internetlänk
Hitta via bibliotek
Till lärosätets databas